| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |